As illustrated above, the signaling axis of CCL2/CCR2 in monocytes/macrophages and T cells has a great impact on cancer immunity, and accumulating evidence also supports the concept that cancerous cells can directly employ CCR2 to promote survival/growth and metastasis. Here, CCL2 is linked to cancer.